Evidence map›Paper›PMID 35047412›Full record

ReviewFrontiers in oncology2021

Imaging Evaluation of Thymoma and Thymic Carcinoma.

Chad D Strange, Jitesh Ahuja, Girish S Shroff, Mylene T Truong, Edith M Marom

Abstract readReview
In one paragraph

Review in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Myasthenia Gravis and Thymoma.Muscle & nerve · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Rare Thymoma With Solitary Liver Metastasis.ACG case reports journal · 2024
    Article
  18. Review
  19. Article
  20. A diagnostic model based onBMC medical imaging · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chad D StrangeDepartment of Thoracic Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Jitesh AhujaDepartment of Thoracic Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Girish S ShroffDepartment of Thoracic Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Mylene T TruongDepartment of Thoracic Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Edith M MaromDepartment of Diagnostic Radiology, Chaim Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Imaging is integral in the management of patients with thymoma and thymic carcinoma. At initial diagnosis and staging, imaging provides the clinical extent of local invasion as well as distant metastases to stratify patients for therapy and to determine prognosis. Following various modalities of therapy, imaging serves to assess treatment response and detect recurrent disease. While imaging findings overlap, a variety of CT, MRI, and PET/CT characteristics can help differentiate thymoma and thymic carcinoma, with new CT and MRI techniques currently under evaluation showing potential.

Indexed as

CTMRIPET/CTthymic carcinomathymoma

Identifiers

PMID35047412
PMCPMC8762255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.